BackgroundCheck.run
Search For

Laura Cook Blumberg, 53246 Aspen Cir, Lincoln Center, MA 01773

Laura Blumberg Phones & Addresses

246 Aspen Cir, Lincoln, MA 01773    617-8066232   

37 Mill St, Lincoln, MA 01773    781-2590809   

5 Division St, Waterford, CT 06385    860-4448957   

Cambridge, MA   

Medford, MA   

Pittsfield, MA   

246 Aspen Cir, Lincoln, MA 01773   

Work

Position: Healthcare Support Occupations

Education

Degree: Associate degree or higher

Mentions for Laura Cook Blumberg

Career records & work history

Lawyers & Attorneys

Laura Blumberg Photo 1

Laura Blumberg - Lawyer

ISLN:
908960017
Admitted:
1982
University:
Emory University, B.A., 1979
Law School:
George Washington University, J.D., 1982

Laura Blumberg resumes & CV records

Resumes

Laura Blumberg Photo 22

Laura Blumberg

Laura Blumberg Photo 23

Laura Blumberg

Laura Blumberg Photo 24

Laura Blumberg

Location:
United States

Publications & IP owners

Us Patents

Pyrazole Compounds As Transforming Growth Factor (Tgf) Inhibitors

US Patent:
6958354, Oct 25, 2005
Filed:
Sep 17, 2003
Appl. No.:
10/667189
Inventors:
Michael J. Munchhof - Salem CT, US
Laura C. Blumberg - Waterford CT, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K031/4439
C07D401/14
US Classification:
514338, 5462684, 5462754, 5462761
Abstract:
Novel pyrazole compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)-β signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer, and fibrotic diseases.

Isothiazole And Isoxazole Compounds As Transforming Growth Factor (Tgf) Inhibitors

US Patent:
7030125, Apr 18, 2006
Filed:
Sep 17, 2003
Appl. No.:
10/667167
Inventors:
Michael J. Munchhof - Salem CT, US
Laura C. Blumberg - Waterford CT, US
Assignee:
Pfizer, Inc. - New York NY
International Classification:
A61K 31/498
C07D 401/14
US Classification:
51425505, 544353, 544354, 544355, 544356
Abstract:
Novel isothiazole and isoxazole compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)-β signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer, and fibrotic diseases.

Triazole Compounds As Transforming Growth Factor (Tgf) Inhibitors

US Patent:
7053095, May 30, 2006
Filed:
Sep 17, 2003
Appl. No.:
10/667183
Inventors:
Michael J. Munchhof - Salem CT, US
Laura C. Blumberg - Waterford CT, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31/517
C07D 401/14
US Classification:
514259, 544284
Abstract:
Novel triazole compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)-β signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer and fibrotic diseases.

Piperazine Derivatives

US Patent:
7098212, Aug 29, 2006
Filed:
Oct 18, 2002
Appl. No.:
10/273658
Inventors:
Laura C. Blumberg - Waterford CT, US
Matthew F. Brown - Stonington CT, US
Matthew M. Hayward - Old Lyme CT, US
Gregory D. Lundquist - Salem CT, US
Christopher S. Poss - North Stonington CT, US
Andrei Shavnya - East Lyme CT, US
International Classification:
A61K 31/506
A61K 31/495
A61K 31/496
C07D 295/00
C07D 403/12
US Classification:
51425214, 51425313, 51425401, 51425402, 51425405, 51425501, 544295, 544365, 544369, 544372, 544391, 544366
Abstract:
The present invention relates to compounds of the formula I.

Pyrazole Compounds As Transforming Growth Factor (Tgf) Inhibitors

US Patent:
7151110, Dec 19, 2006
Filed:
Sep 23, 2005
Appl. No.:
11/234564
Inventors:
Michael J. Munchhof - Salem CT, US
Laura C. Blumberg - Waterford CT, US
Assignee:
Pfizer Inc. - New York NY
Pfizer Products Inc. - Groton CT
International Classification:
A61K 31/4709
C07D 401/14
US Classification:
514312, 514313, 514314, 546153, 546156, 546157, 546159, 546162, 546167
Abstract:
Novel pyrazole compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)-β signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer, and fibrotic diseases.

Imidazole Compounds As Transforming Growth Factor (Tgf) Inhibitors

US Patent:
7153872, Dec 26, 2006
Filed:
Sep 17, 2003
Appl. No.:
10/666192
Inventors:
Michael J. Munchhof - Salem CT, US
Laura C. Blumberg - Waterford CT, US
Assignee:
Pfizer Inc. - New York NY
Pfizer Products Inc. - Groton CT
International Classification:
A61K 31/44
C07D 401/04
US Classification:
514339, 5462681, 5462727, 5462741, 514336
Abstract:
Novel imidazole compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)-β signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer and fibrotic diseases.

Oxazole And Thiazole Compounds As Transforming Growth Factor (Tgf) Inhibitors

US Patent:
7273936, Sep 25, 2007
Filed:
Sep 17, 2003
Appl. No.:
10/667187
Inventors:
Michael J. Munchhof - Salem CT, US
Laura C. Blumberg - Waterford CT, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31/44
US Classification:
546122, 5462684, 546164, 5462714, 544284, 544353
Abstract:
Novel oxazole and thiazole compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)-β signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer and fibrotic diseases.

Imidazopyrimidines As Transforming Growth Factor (Tgf) Inhibitors

US Patent:
7417041, Aug 26, 2008
Filed:
Feb 20, 2004
Appl. No.:
10/783251
Inventors:
Laura C. Blumberg - Waterford CT, US
Michael J. Munchhof - Salem CT, US
Andrei Shavnya - East Lyme CT, US
Assignee:
Pfizer Inc. - New York NY
Pfizer Products Inc. - Groton CT
International Classification:
A61K 31/538
A61K 31/519
A61K 31/517
A61K 31/5025
A61K 31/502
A61K 31/4439
A61K 31/437
A61K 31/4375
A61K 31/4704
C07D 265/36
C07D 487/04
C07D 401/14
C07D 241/40
C07D 471/04
C07D 221/04
C07D 215/12
C07D 213/26
US Classification:
5142305, 544105, 544263, 544281, 544284, 544235, 544353, 544333, 546117, 546119, 546120, 546121, 546122, 546112, 546250, 51425931, 5142662, 514248, 514249, 514256, 514300, 514303, 514299, 514332, 514341
Abstract:
Novel fused heteroaromatic compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)-β signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer and fibrotic diseases.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.